À¶Ý®ÊÓƵ

Evaluation of ADG20 for the Prevention of COVID-19

Trial ID or NCT#

NCT04859517

Status

not recruiting iconNOT RECRUITING

Purpose

This placebo-controlled study is intended to evaluate ADG20's safety and ability to prevent COVID-19 infection.

Official Title

A Phase 2/3 Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Prevention of COVID-19 (EVADE)

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Peter Schmidt
Peter Schmidt
Anesthesiologist, Pain management specialist
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

View on